A Single and Multiple Ascending Doses Study to Evaluate the Safety and Pharmacokinetics of RBD5044
Clinical trial NCT05539651 · COMPLETED
Trial details
- NCT number
- NCT05539651
- Sponsor
- Suzhou Ribo Life Science Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2024-10-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.